Drugmaker GSK settles another California lawsuit on heartburn drug Zantac
(Reuters) -GSK on Wednesday said it would confidentially settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused
2023-10-11 15:53
Companies Get Renewed Pressure to Disclose Nature-Related Risks
Executives from companies, banks and asset managers published guidelines aimed at helping businesses disclose the risks they face
2023-09-19 06:50
GSK sues Pfizer in US for patent infringement over RSV vaccine
By Blake Brittain (Reuters) -British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer's respiratory
2023-08-02 22:20
GSK Raises Outlook, Looks to New Medicines to Fuel Growth
GSK Plc raised its guidance for the year after a strong start to 2023 as it prepares to
2023-07-26 15:15
GSK's RSV vaccine shows long-term efficacy in late-stage trial
(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong
2023-06-21 14:48
Only Labour Can Fix the NHS, Says Boris Johnson’s Vaccine Czar
The National Health Service is “hopeless” and needs a “complete restructuring,” says the woman behind one of its
2023-06-15 12:28
EU approves its first vaccine for common respiratory virus RSV
By Natalie Grover and Eva Mathews (Reuters) -European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV),
2023-06-07 16:17
GSK's cancer drug Jemperli gets file acceptance from US FDA
GSK said on Tuesday that the U.S. Food and Drug Administration had granted file acceptance for its cancer
2023-06-06 15:16
French Drugmaker Weighs Bids For Scottish Site Behind Covid Debacle
Valneva SE has been approached by about a dozen potential buyers for its Scottish manufacturing site, according to
2023-05-26 19:48